Ophthalmological and Biological Features of the Oculorespiratory Syndrome after Influenza Vaccination
http://www.journals.uchicago.edu/doi/pdf/10.1086/378294

 

Marie JoseŽe Fredette, Gaston De Serres, and Mario Malenfant Centre Hospitalier Universitaire de Laval (CHUL) Research Center, Centre Hospitalier Universitaire de QueŽbec, CHUL, Laval University, Ste-Foy, and 2Institut National de SanteŽ Publique du QueŽbec, QueŽbec, Canada

During the autumn of 2000, oculorespiratory syndrome (ORS),
a new adverse event associated with influenza vaccination, was
identified in Canada [1–5]. The clinical case definition required
that, within 24 h after influenza vaccination, the patient develop
1 of the following symptoms: bilateral red eyes, respiratory
symptoms (i.e., cough, wheezing, difficulty breathing, difficulty
swallowing, hoarseness, chest tightness, and/or sore throat), and
facial edema [5]. We report the findings for 6 patients with
ORS with red eyes who had a complete ophthalmological examination
and a standardized laboratory blood investigation.